Oncotelic Therapeutics Inc
(OTLC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 84 | 200 | 3 | 1,058 | 1,966 |
| TOTAL | $189 | $340 | $3 | $1,149 | $2,066 |
| Non-Current Assets | |||||
| Investments And Advances | 1,769 | 0 | 1,769 | 0 | 0 |
| Intangibles | 5,701 | 0 | 976 | 0 | 0 |
| Other Non-Current Assets | 0 | 51 | 0 | 0 | 33 |
| TOTAL | $7,471 | $51 | $2,745 | $N/A | $33 |
| Total Assets | $7,660 | $391 | $2,748 | $1,149 | $2,099 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 228 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1,815 | 901 | 283 | 772 | 1,221 |
| Accrued Expenses | N/A | 175 | N/A | 119 | 168 |
| Other current liabilities | N/A | 55 | N/A | N/A | N/A |
| TOTAL | $2,043 | $1,174 | $283 | $1,091 | $1,561 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,043 | $1,174 | $283 | $1,091 | $1,561 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 82,451 | 82,101 | 41,420 | 41,420 | 41,420 |
| Common Shares | 835 | 414 | 68 | 414 | 414 |
| Retained earnings | -7,655 | -295,645 | -5,490 | -294,386 | -293,711 |
| Other shareholders' equity | 2 | 0 | 0 | 0 | 0 |
| TOTAL | $5,617 | $-783 | $2,465 | $58 | $538 |
| Total Liabilities And Equity | $7,660 | $391 | $2,748 | $1,149 | $2,099 |